GSK Settles Zantac Lawsuits: A New Chapter for the Controversial Drug
The concerns surrounding Zantac also prompted UK health authorities to advise doctors in 2019 to cease prescribing specific formulations of the drug as a precautionary measure. Reports indicated that certain versions might contain impurities linked to cancer,
InvestorsHub on MSN3d
Tesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits; 10x Genomics Stock Drops on Revenue ForecastTesla’s sales in China increased by 19.2% in September, totaling over 72,000 electric vehicles sold, its best performance of ...
European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease ...
LONDON — UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts ...
A town centre bakery has been closed this morning, October 11. Greggs on Deansgate is closed for business, with the shutters ...
Inspectas, in Drighlington, has appointed new staff from trainee to board level, adding expertise in various fields. This ...
Lenders report that default rates on secured loans to UK households increased in Q3 2024 and are expected to increase again ...
The Bureau of Labour Statistics added that core inflation which excludes food and energy rose by 3.3% over the last year. The ...
Bar Rua on the corner of Clarendon Street and Chatham Row/Chatham Street has been put on the market as Galway Bay Brewery ...
Take up of large industrial property in Wales fell sharply in the third quarter (Q3) of this year, according to new research ...
Europe's main equity indices were little changed in midday deals after yet more record-highs Wednesday on Wall Street ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback